4//SEC Filing
Khan Najat 4
Accession 0001601830-25-000131
CIK 0001601830other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:22 PM ET
Size
6.5 KB
Accession
0001601830-25-000131
Insider Transaction Report
Form 4
Khan Najat
DirectorChief R&D Commercial Officer
Transactions
- Tax Payment
Class A Common Stock
2025-08-15$5.64/sh−3,789$21,370→ 704,796 total - Sale
Class A Common Stock
2025-08-18$5.52/sh−36,599$202,173→ 668,197 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F2]Represents shares that have been required to be sold by the Issuer to satisfy the tax withholding and remittance obligations in connection with the vesting of restricted stock units.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0002020969
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:22 PM ET
- Size
- 6.5 KB